Recombinant human erythropoietin for the correction of cancer associated anemia with and without concomitant cytotoxic chemotherapy.

H, Ludwig; E, Sundal; M, Pecherstorfer; C, Leitgeb; T, Bauernhofer; A, Beinhauer; H, Samonigg; AW, Kappeler; E, Fritz

doi:10.1002/1097-0142(19951201)76:11<2319::aid-cncr2820761121>3.0.co;2-u

Public

Recombinant human erythropoietin for the correction of cancer associated anemia with and without concomitant cytotoxic chemotherapy.

Shared by NobleBlocks on Dec 1, 1995 • 12:00 AM UTC

Authors:

Ludwig H

Sundal E

Pecherstorfer M

Abstract

<h4>Background</h4>Chronic anemia is a common complication in patients with cancer, especially in those with advanced disease or who are under intensive chemotherapy. Because homologous blood transfusions involve some hazards, the safety and efficacy of recombinant human erythropoietin (r-HuEPO) in ...

Discussions